ES511156A0 - Un metodo de determinar la presencia de un antigeno en un medio liquido sospechoso de contenerlo. - Google Patents

Un metodo de determinar la presencia de un antigeno en un medio liquido sospechoso de contenerlo.

Info

Publication number
ES511156A0
ES511156A0 ES511156A ES511156A ES511156A0 ES 511156 A0 ES511156 A0 ES 511156A0 ES 511156 A ES511156 A ES 511156A ES 511156 A ES511156 A ES 511156A ES 511156 A0 ES511156 A0 ES 511156A0
Authority
ES
Spain
Prior art keywords
liquid medium
antigen
contain
determining
phase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES511156A
Other languages
English (en)
Other versions
ES8307897A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CNA Holdings LLC
Original Assignee
American Hoechst Corp
Hoechst Celanese Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Hoechst Corp, Hoechst Celanese Corp filed Critical American Hoechst Corp
Publication of ES8307897A1 publication Critical patent/ES8307897A1/es
Publication of ES511156A0 publication Critical patent/ES511156A0/es
Granted legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306Solid-phase reaction mechanisms
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
ES511156A 1981-04-13 1982-04-05 Un metodo de determinar la presencia de un antigeno en un medio liquido sospechoso de contenerlo. Granted ES511156A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25360781A 1981-04-13 1981-04-13

Publications (2)

Publication Number Publication Date
ES8307897A1 ES8307897A1 (es) 1983-08-01
ES511156A0 true ES511156A0 (es) 1983-08-01

Family

ID=22960970

Family Applications (1)

Application Number Title Priority Date Filing Date
ES511156A Granted ES511156A0 (es) 1981-04-13 1982-04-05 Un metodo de determinar la presencia de un antigeno en un medio liquido sospechoso de contenerlo.

Country Status (7)

Country Link
EP (1) EP0062892B1 (es)
JP (1) JPS57179750A (es)
AT (1) ATE16131T1 (es)
AU (1) AU559469B2 (es)
CA (1) CA1180659A (es)
DE (1) DE3266896D1 (es)
ES (1) ES511156A0 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK76983A (da) * 1982-03-05 1983-09-06 Takeda Chemical Industries Ltd Fremgangsmaade og reagens til immunkemisk bestemmelse af humant choriogonadotropin
WO1984004598A1 (en) * 1983-05-06 1984-11-22 Univ Columbia Immunoassay for human chorionic gonadotropin
WO1985000663A1 (en) * 1983-07-25 1985-02-14 Beckman Instruments, Inc. Immunometric assay using polyclonal and monoclonal antibodies and a kit for use therein
GB8328918D0 (en) * 1983-10-28 1983-11-30 Unilever Plc Alkaline phosphatase
US4595661A (en) * 1983-11-18 1986-06-17 Beckman Instruments, Inc. Immunoassays and kits for use therein which include low affinity antibodies for reducing the hook effect
US4666865A (en) * 1984-01-13 1987-05-19 Centocor, Inc. Immunoassay for biologically active human interferon-gamma employing unique monoclonal antibodies
FR2560996B1 (fr) * 1984-03-09 1988-01-15 Commissariat Energie Atomique Procede de dosage immunologique d'antigenes, d'anticorps ou d'haptenes, son utilisation pour le dosage des lipoproteines et de l'a-foetoproteine et trousses de dosage pour la mise en oeuvre de ce procede
US4748111A (en) * 1984-03-12 1988-05-31 Molecular Diagnostics, Inc. Nucleic acid-protein conjugate used in immunoassay
EP0155224A3 (en) * 1984-03-15 1987-05-06 CHROMAGENICS, Inc. Solid-borne complex bearing chromagen responsive functionality for antibody, antigen, receptor, or ligand detection
US5011771A (en) * 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
AU590746B2 (en) * 1985-03-06 1989-11-16 Fuji Yakuhin Kogyo Kabushiki Kaisha Method for determining human prolyl 4-hydroxylase by immunoassay
EP0225709B1 (en) * 1985-10-22 1992-05-27 Centocor, Inc. Immunometric assay for high molecular weight carcinoembryonic antigen
DE3633497A1 (de) * 1986-10-02 1988-04-14 Hoechst Ag Immunometrisches bestimmungsverfahren
JP2657816B2 (ja) * 1988-03-31 1997-09-30 雪印乳業株式会社 エリスロポエチンの免疫学的測定法
DE3837616A1 (de) * 1988-11-05 1990-05-10 Behringwerke Ag Einschritt-immuntest zur bestimmung von antigen-spezifischen antikoerpern aller immunglobulin-klassen und dazu geeignetes mittel

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154599B (nl) * 1970-12-28 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
DE2548963C3 (de) * 1975-11-03 1982-03-11 Merck Patent Gmbh, 6100 Darmstadt Verfahren und Mittel zur Bestimmung der Aktivität von Creatinkinase-MB
IL48741A (en) * 1975-12-26 1979-07-25 Rafa Labor Ltd Method for the determination of pregnancy
JPS5347518A (en) * 1976-10-07 1978-04-28 Mochida Pharm Co Ltd Immunologically measuring method
GB1549069A (en) * 1976-12-10 1979-08-01 Erba Farmitalia Enzyme linked immunoassay
FR2385099A1 (fr) * 1977-03-21 1978-10-20 Stago Diagnostica Methode de determination immuno-enzymologique
US4123343A (en) * 1977-06-14 1978-10-31 American Home Products Corporation Purification of glycoproteins and immunization therewith
US4244940A (en) * 1978-09-05 1981-01-13 Bio-Rad Laboratories, Inc. Single-incubation two-site immunoassay
CH642458A5 (en) * 1980-04-25 1984-04-13 Hoffmann La Roche Immunological method
WO1982000058A1 (en) * 1980-06-20 1982-01-07 Porter P Processes and apparatus for carrying out specific binding assays
SE8006424L (sv) * 1980-09-12 1982-03-13 Jolla Cancer Res Found Sett att bestemma ett antigen i losning
DE3174064D1 (en) * 1980-10-15 1986-04-17 Takeda Chemical Industries Ltd Method for immunochemical assay and kit therefor

Also Published As

Publication number Publication date
ES8307897A1 (es) 1983-08-01
ATE16131T1 (de) 1985-11-15
JPS57179750A (en) 1982-11-05
EP0062892A1 (en) 1982-10-20
CA1180659A (en) 1985-01-08
DE3266896D1 (en) 1985-11-21
AU559469B2 (en) 1987-03-12
EP0062892B1 (en) 1985-10-16
AU8256182A (en) 1982-10-21

Similar Documents

Publication Publication Date Title
ES511156A0 (es) Un metodo de determinar la presencia de un antigeno en un medio liquido sospechoso de contenerlo.
DK343679A (da) Immunologisk fremgangsmaade til bestemmelse af et immunkompleks i en vaeske samt det ved frmegangsmaaden anvendte diagnostiske middel
DK212986A (da) Fremgangsmaade til bestemmelse af et stof i en praeve
DK265688A (da) Fastfaseanalyse under anvendelse af kapillarstroemning
EP0005271A3 (en) Method and kit for enzyme immunoassay of biological substances
FR2630827B1 (fr) Dispositif et procede pour la determination qualitative et quantitative rapide de la presence d'un ligand reactif dans un fluide
DE3485920D1 (de) Kolorimetrisches immunoessay auf fester oberflaeche, sowie dazu zu verwendender teststab und seine herstellung.
DK158284A (da) Monoklonale antistoffer afledt af tvaerbundne fibrinderivater samt analysemetode til bestemmelse af disse derivater
ATE113962T1 (de) Von polypeptiden induzierte monoklonale antikörper gegen oncoproteine.
SE7907535L (sv) Diagnostiskt forfarande
NO159820C (no) Fremgangsmaate ved bestemmelse av antigen-antistoff-reaksjoner.
EP0113075A3 (en) Field immunoassay reaction system, method of immunoassay diagnosis and probe or carrier for use therewith
DE3850249D1 (de) Nachweis von analyt in partikel enthaltenden proben.
KR850002385A (ko) PIVKA-Ⅱ의 측정(assay)용 방법 및 시약
DK0492499T3 (da) Fremgangsmåde til bestemmelse af en analyt
EP0287731A3 (en) Dry test strips having a red blood cell exclusion layer
ES8706966A1 (es) Metodo de ensayar muestras de fluido en cuanto a la presencia de anticuerpos contra un microorganismo y dispositivo correspondiente
ATE80740T1 (de) Immunassay-verfahren.
KR940000870A (ko) β-N- 아세틸글루코사미니다제의 샌드위치 면역 측정법 및 그 측정법에 사용된 모노클론 항체
WO1998022825A3 (en) A whole blood/mitogen assay for the early detection of a subject with cancer and kit
KR850008620A (ko) Atl 바이러스 항체의 측정방법 및 시약
JPS57131062A (en) Quantitative determination of antigen using enzyme- labelled antigen and second antibody insolubilizing carrier
NO881998L (no) Fremgangsmaate til kvantitativ bestemmelse av serumproteiner i kroppsvaesker og middel til gjennomfoering av fremgangsmaaten.
DE69616509D1 (de) A-protein als diagnostikum für krebs
JPS5347517A (en) Immobilized antibody membrane for antigen protein determinationmethod and its apparatus

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970203